| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Porifera | 49 | 2021 | 58 | 9.320 |
Why?
|
| Biological Products | 21 | 2021 | 78 | 6.650 |
Why?
|
| Carbazoles | 17 | 2021 | 46 | 4.590 |
Why?
|
| Antineoplastic Agents | 24 | 2022 | 1070 | 4.250 |
Why?
|
| Depsipeptides | 10 | 2022 | 21 | 3.830 |
Why?
|
| Alkaloids | 16 | 2014 | 40 | 3.710 |
Why?
|
| Antimalarials | 21 | 2014 | 71 | 3.370 |
Why?
|
| Marine Biology | 20 | 2019 | 23 | 3.360 |
Why?
|
| Anti-Infective Agents | 14 | 2022 | 166 | 3.270 |
Why?
|
| Molecular Structure | 48 | 2022 | 397 | 3.170 |
Why?
|
| Indole Alkaloids | 9 | 2019 | 18 | 3.090 |
Why?
|
| Anti-Bacterial Agents | 19 | 2020 | 1026 | 2.240 |
Why?
|
| Antiviral Agents | 10 | 2021 | 211 | 2.180 |
Why?
|
| Antifungal Agents | 15 | 2022 | 108 | 2.170 |
Why?
|
| Antiprotozoal Agents | 12 | 2014 | 23 | 2.020 |
Why?
|
| Animals | 99 | 2022 | 20881 | 1.920 |
Why?
|
| Aquatic Organisms | 6 | 2021 | 9 | 1.870 |
Why?
|
| Plasmodium falciparum | 17 | 2014 | 45 | 1.810 |
Why?
|
| Anti-HIV Agents | 10 | 2008 | 135 | 1.700 |
Why?
|
| Kadsura | 5 | 2019 | 9 | 1.660 |
Why?
|
| Drug Discovery | 8 | 2021 | 94 | 1.600 |
Why?
|
| Carbolines | 8 | 2009 | 19 | 1.510 |
Why?
|
| Triterpenes | 4 | 2017 | 40 | 1.490 |
Why?
|
| Antidepressive Agents | 5 | 2020 | 216 | 1.440 |
Why?
|
| Plant Extracts | 7 | 2018 | 122 | 1.400 |
Why?
|
| Endangered Species | 3 | 2013 | 9 | 1.310 |
Why?
|
| Peptides, Cyclic | 7 | 2011 | 35 | 1.240 |
Why?
|
| Structure-Activity Relationship | 17 | 2020 | 420 | 1.220 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2021 | 300 | 1.200 |
Why?
|
| Microbial Sensitivity Tests | 20 | 2019 | 226 | 1.180 |
Why?
|
| Magnetic Resonance Spectroscopy | 22 | 2021 | 346 | 1.150 |
Why?
|
| Antineoplastic Agents, Phytogenic | 5 | 2018 | 88 | 1.130 |
Why?
|
| Mycobacterium tuberculosis | 11 | 2018 | 103 | 1.130 |
Why?
|
| Sesquiterpenes | 8 | 2018 | 41 | 1.120 |
Why?
|
| Mollusca | 5 | 2022 | 14 | 1.110 |
Why?
|
| Cryptococcus neoformans | 6 | 2022 | 24 | 1.040 |
Why?
|
| Stereoisomerism | 16 | 2019 | 169 | 1.040 |
Why?
|
| Drug Screening Assays, Antitumor | 14 | 2019 | 111 | 1.030 |
Why?
|
| Protective Agents | 3 | 2021 | 36 | 0.930 |
Why?
|
| Biological Factors | 4 | 2005 | 11 | 0.910 |
Why?
|
| N,N-Dimethyltryptamine | 2 | 2017 | 2 | 0.910 |
Why?
|
| Hydrocarbons, Brominated | 2 | 2017 | 7 | 0.900 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 3 | 2009 | 64 | 0.900 |
Why?
|
| Indoles | 6 | 2017 | 146 | 0.890 |
Why?
|
| Pyrans | 2 | 2015 | 16 | 0.890 |
Why?
|
| Antitubercular Agents | 8 | 2018 | 57 | 0.880 |
Why?
|
| HIV-1 | 7 | 2007 | 177 | 0.870 |
Why?
|
| Lindera | 2 | 2013 | 3 | 0.860 |
Why?
|
| Chlorophyta | 2 | 2015 | 5 | 0.860 |
Why?
|
| Naphthyridines | 3 | 2008 | 20 | 0.860 |
Why?
|
| Inhibitory Concentration 50 | 15 | 2016 | 73 | 0.820 |
Why?
|
| Chromatography, Thin Layer | 1 | 2021 | 52 | 0.810 |
Why?
|
| Metabolomics | 1 | 2021 | 28 | 0.800 |
Why?
|
| Terpenes | 4 | 2021 | 18 | 0.790 |
Why?
|
| Humans | 70 | 2022 | 68618 | 0.780 |
Why?
|
| Orchidaceae | 1 | 2021 | 2 | 0.770 |
Why?
|
| Succinates | 1 | 2021 | 9 | 0.760 |
Why?
|
| Pyrroles | 6 | 2007 | 83 | 0.750 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 5 | 2019 | 92 | 0.740 |
Why?
|
| Cell Line, Tumor | 11 | 2020 | 1851 | 0.720 |
Why?
|
| Symbiosis | 1 | 2020 | 19 | 0.720 |
Why?
|
| Betacoronavirus | 1 | 2021 | 116 | 0.710 |
Why?
|
| Thiazolidines | 3 | 2009 | 23 | 0.710 |
Why?
|
| Immune System | 4 | 2009 | 63 | 0.690 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 14 | 2018 | 85 | 0.680 |
Why?
|
| Receptors, Serotonin | 2 | 2017 | 74 | 0.670 |
Why?
|
| Hep G2 Cells | 6 | 2021 | 68 | 0.670 |
Why?
|
| Peptides | 4 | 2017 | 455 | 0.660 |
Why?
|
| Kaempferols | 3 | 2019 | 3 | 0.660 |
Why?
|
| Colonic Neoplasms | 4 | 2018 | 299 | 0.660 |
Why?
|
| Homeodomain Proteins | 1 | 2020 | 157 | 0.650 |
Why?
|
| Models, Chemical | 3 | 2019 | 155 | 0.650 |
Why?
|
| Nervous System | 3 | 2009 | 45 | 0.650 |
Why?
|
| Lactones | 4 | 2022 | 64 | 0.650 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2008 | 64 | 0.640 |
Why?
|
| Plants, Medicinal | 4 | 2014 | 43 | 0.640 |
Why?
|
| Food Coloring Agents | 1 | 2018 | 2 | 0.640 |
Why?
|
| Liver Neoplasms | 2 | 2022 | 334 | 0.640 |
Why?
|
| Citrus | 1 | 2018 | 12 | 0.630 |
Why?
|
| Chromatography, High Pressure Liquid | 7 | 2018 | 381 | 0.620 |
Why?
|
| Indonesia | 7 | 2021 | 11 | 0.620 |
Why?
|
| Diterpenes | 3 | 2014 | 42 | 0.620 |
Why?
|
| Cardiovascular System | 3 | 2009 | 85 | 0.620 |
Why?
|
| Cell Proliferation | 5 | 2018 | 1174 | 0.610 |
Why?
|
| Peptide Biosynthesis | 1 | 2017 | 5 | 0.600 |
Why?
|
| Molecular Conformation | 9 | 2021 | 128 | 0.580 |
Why?
|
| Actins | 2 | 2009 | 249 | 0.580 |
Why?
|
| Anti-Inflammatory Agents | 5 | 2007 | 234 | 0.570 |
Why?
|
| Apoptosis | 4 | 2020 | 1641 | 0.550 |
Why?
|
| Fusarium | 2 | 2014 | 5 | 0.550 |
Why?
|
| Models, Molecular | 11 | 2018 | 546 | 0.540 |
Why?
|
| Plasmodium berghei | 4 | 2010 | 7 | 0.540 |
Why?
|
| Cornus | 2 | 2014 | 2 | 0.530 |
Why?
|
| Seawater | 2 | 2013 | 29 | 0.530 |
Why?
|
| Pancreatic Neoplasms | 1 | 2019 | 332 | 0.520 |
Why?
|
| beta Catenin | 2 | 2018 | 73 | 0.520 |
Why?
|
| Circular Dichroism | 7 | 2019 | 99 | 0.520 |
Why?
|
| Leishmania donovani | 8 | 2012 | 19 | 0.520 |
Why?
|
| Quinones | 2 | 2018 | 13 | 0.510 |
Why?
|
| Eutrophication | 1 | 2015 | 5 | 0.510 |
Why?
|
| Mice | 20 | 2022 | 8474 | 0.510 |
Why?
|
| Acetaminophen | 3 | 2022 | 111 | 0.510 |
Why?
|
| Drug Resistance, Fungal | 2 | 2016 | 8 | 0.500 |
Why?
|
| Neoplasms | 2 | 2022 | 1667 | 0.480 |
Why?
|
| Persea | 1 | 2014 | 1 | 0.480 |
Why?
|
| Jatropha | 1 | 2014 | 1 | 0.480 |
Why?
|
| Apocynaceae | 1 | 2014 | 2 | 0.480 |
Why?
|
| Alzheimer Disease | 3 | 2014 | 565 | 0.480 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 362 | 0.480 |
Why?
|
| Enzyme Inhibitors | 5 | 2021 | 659 | 0.470 |
Why?
|
| Tyrosine | 2 | 2005 | 196 | 0.470 |
Why?
|
| Vibrio | 2 | 2013 | 14 | 0.460 |
Why?
|
| Asteraceae | 1 | 2013 | 4 | 0.460 |
Why?
|
| Crystallography, X-Ray | 8 | 2018 | 190 | 0.450 |
Why?
|
| Dinoflagellida | 2 | 2010 | 5 | 0.450 |
Why?
|
| Monoterpenes | 1 | 2013 | 8 | 0.440 |
Why?
|
| Antihypertensive Agents | 1 | 2017 | 498 | 0.440 |
Why?
|
| Hydroquinones | 1 | 2013 | 15 | 0.440 |
Why?
|
| Pyrroloiminoquinones | 1 | 2013 | 1 | 0.440 |
Why?
|
| Tyramine | 2 | 2004 | 16 | 0.430 |
Why?
|
| Geologic Sediments | 1 | 2013 | 75 | 0.430 |
Why?
|
| Mycobacterium avium Complex | 2 | 2009 | 16 | 0.420 |
Why?
|
| Methicillin Resistance | 2 | 2009 | 45 | 0.420 |
Why?
|
| Anti-Anxiety Agents | 2 | 2010 | 107 | 0.420 |
Why?
|
| Ticks | 1 | 2012 | 13 | 0.420 |
Why?
|
| Culicidae | 1 | 2012 | 12 | 0.420 |
Why?
|
| Insect Repellents | 1 | 2012 | 8 | 0.420 |
Why?
|
| Nitro Compounds | 1 | 2012 | 11 | 0.410 |
Why?
|
| Volatile Organic Compounds | 1 | 2012 | 14 | 0.410 |
Why?
|
| Iridoid Glycosides | 1 | 2012 | 1 | 0.410 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2012 | 5 | 0.410 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2012 | 7 | 0.410 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2013 | 133 | 0.410 |
Why?
|
| Glycosides | 2 | 2022 | 14 | 0.400 |
Why?
|
| Polyketides | 3 | 2018 | 3 | 0.380 |
Why?
|
| Ascomycota | 2 | 2022 | 8 | 0.380 |
Why?
|
| Molecular Docking Simulation | 4 | 2021 | 78 | 0.380 |
Why?
|
| Bacillus megaterium | 2 | 2000 | 2 | 0.370 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2010 | 35 | 0.370 |
Why?
|
| Staphylococcal Infections | 3 | 2019 | 156 | 0.360 |
Why?
|
| Marine Toxins | 1 | 2010 | 14 | 0.360 |
Why?
|
| Neurogenic Inflammation | 1 | 2010 | 4 | 0.350 |
Why?
|
| Cerebellar Diseases | 1 | 2010 | 6 | 0.350 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 2009 | 5 | 0.350 |
Why?
|
| Ostreidae | 1 | 2009 | 7 | 0.350 |
Why?
|
| Shellfish | 1 | 2009 | 8 | 0.350 |
Why?
|
| Phytotherapy | 3 | 2013 | 53 | 0.350 |
Why?
|
| Trees | 1 | 2009 | 8 | 0.350 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2010 | 34 | 0.350 |
Why?
|
| Bacteria | 4 | 2020 | 193 | 0.350 |
Why?
|
| Food Handling | 1 | 2009 | 34 | 0.340 |
Why?
|
| Carbon Dioxide | 1 | 2009 | 78 | 0.340 |
Why?
|
| Neuroprotective Agents | 2 | 2018 | 317 | 0.340 |
Why?
|
| Antiparasitic Agents | 2 | 2007 | 12 | 0.340 |
Why?
|
| Lignans | 2 | 2019 | 10 | 0.330 |
Why?
|
| Oils, Volatile | 3 | 2012 | 9 | 0.330 |
Why?
|
| Amides | 1 | 2009 | 86 | 0.330 |
Why?
|
| Mass Spectrometry | 5 | 2021 | 284 | 0.320 |
Why?
|
| Urochordata | 1 | 2008 | 4 | 0.320 |
Why?
|
| Alaska | 3 | 2019 | 7 | 0.320 |
Why?
|
| Cell Survival | 4 | 2021 | 901 | 0.320 |
Why?
|
| Jamaica | 6 | 2006 | 10 | 0.320 |
Why?
|
| Prodrugs | 1 | 2008 | 54 | 0.310 |
Why?
|
| Drugs, Investigational | 2 | 2004 | 18 | 0.300 |
Why?
|
| Receptor, ErbB-3 | 1 | 2007 | 17 | 0.300 |
Why?
|
| Dioxanes | 2 | 2011 | 15 | 0.290 |
Why?
|
| Oceans and Seas | 5 | 2014 | 10 | 0.290 |
Why?
|
| Tumor Cells, Cultured | 8 | 2006 | 852 | 0.290 |
Why?
|
| X-Ray Diffraction | 2 | 2017 | 53 | 0.290 |
Why?
|
| Anxiety | 1 | 2010 | 422 | 0.290 |
Why?
|
| Bacterial Proteins | 2 | 2019 | 245 | 0.280 |
Why?
|
| Lysosomes | 1 | 2007 | 136 | 0.280 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2018 | 201 | 0.280 |
Why?
|
| Araceae | 1 | 2006 | 1 | 0.280 |
Why?
|
| Dreissena | 1 | 2006 | 1 | 0.280 |
Why?
|
| Hawaii | 3 | 2013 | 24 | 0.280 |
Why?
|
| Communicable Diseases | 1 | 2007 | 50 | 0.270 |
Why?
|
| Streptomyces | 1 | 2006 | 15 | 0.270 |
Why?
|
| Anticonvulsants | 1 | 2008 | 223 | 0.270 |
Why?
|
| Apiaceae | 2 | 2008 | 2 | 0.270 |
Why?
|
| Parasitic Diseases | 1 | 2005 | 9 | 0.260 |
Why?
|
| Vero Cells | 4 | 2008 | 13 | 0.260 |
Why?
|
| Polyenes | 1 | 2005 | 2 | 0.260 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 240 | 0.260 |
Why?
|
| Oxygen | 1 | 2007 | 386 | 0.260 |
Why?
|
| Ecosystem | 3 | 2020 | 54 | 0.260 |
Why?
|
| Thiazoles | 1 | 2006 | 95 | 0.260 |
Why?
|
| Liver | 3 | 2022 | 1118 | 0.260 |
Why?
|
| Spectrophotometry, Ultraviolet | 5 | 2008 | 79 | 0.250 |
Why?
|
| DNA | 1 | 2008 | 597 | 0.250 |
Why?
|
| Bivalvia | 1 | 2004 | 10 | 0.250 |
Why?
|
| Mycoses | 1 | 2005 | 60 | 0.250 |
Why?
|
| Plant Leaves | 4 | 2018 | 49 | 0.250 |
Why?
|
| Protein Synthesis Inhibitors | 2 | 2019 | 32 | 0.240 |
Why?
|
| Water | 2 | 2018 | 230 | 0.240 |
Why?
|
| Fungi | 2 | 2020 | 27 | 0.240 |
Why?
|
| Nervous System Diseases | 1 | 2005 | 142 | 0.240 |
Why?
|
| Quinolines | 1 | 2004 | 48 | 0.230 |
Why?
|
| Ceramides | 1 | 2008 | 578 | 0.230 |
Why?
|
| Drug Design | 3 | 2014 | 107 | 0.230 |
Why?
|
| Administration, Oral | 4 | 2013 | 411 | 0.230 |
Why?
|
| Pharmacognosy | 1 | 2003 | 2 | 0.230 |
Why?
|
| Computer Simulation | 3 | 2016 | 706 | 0.230 |
Why?
|
| Protein Biosynthesis | 2 | 2019 | 181 | 0.230 |
Why?
|
| Spiro Compounds | 2 | 2016 | 14 | 0.230 |
Why?
|
| Cystine | 2 | 2014 | 20 | 0.230 |
Why?
|
| Nucleosides | 1 | 2003 | 9 | 0.220 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2004 | 98 | 0.220 |
Why?
|
| Depression | 1 | 2010 | 943 | 0.220 |
Why?
|
| Daphne | 1 | 2022 | 1 | 0.220 |
Why?
|
| Antifreeze Proteins | 1 | 2002 | 3 | 0.220 |
Why?
|
| Magnoliopsida | 2 | 2015 | 5 | 0.220 |
Why?
|
| China | 2 | 2021 | 138 | 0.210 |
Why?
|
| Ergosterol | 1 | 2002 | 3 | 0.210 |
Why?
|
| Biotransformation | 4 | 2007 | 69 | 0.210 |
Why?
|
| Pharmacology | 1 | 2002 | 9 | 0.210 |
Why?
|
| Plant Roots | 2 | 2019 | 22 | 0.200 |
Why?
|
| Phylogeography | 1 | 2021 | 4 | 0.200 |
Why?
|
| Binding Sites | 4 | 2018 | 631 | 0.200 |
Why?
|
| Bromobenzenes | 1 | 2001 | 4 | 0.200 |
Why?
|
| Databases, Chemical | 1 | 2021 | 3 | 0.200 |
Why?
|
| Principal Component Analysis | 1 | 2021 | 55 | 0.200 |
Why?
|
| Cyclooctanes | 2 | 2019 | 5 | 0.200 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2021 | 3 | 0.200 |
Why?
|
| Spectrum Analysis | 4 | 2005 | 81 | 0.200 |
Why?
|
| Databases, Protein | 1 | 2021 | 49 | 0.200 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 223 | 0.190 |
Why?
|
| Protein Interaction Mapping | 1 | 2021 | 62 | 0.190 |
Why?
|
| Cluster Analysis | 1 | 2021 | 219 | 0.190 |
Why?
|
| Phytochemicals | 1 | 2021 | 6 | 0.190 |
Why?
|
| Cunninghamella | 1 | 2000 | 1 | 0.190 |
Why?
|
| Rats | 6 | 2018 | 5300 | 0.190 |
Why?
|
| Furans | 2 | 2003 | 27 | 0.190 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2021 | 147 | 0.190 |
Why?
|
| HeLa Cells | 2 | 2020 | 237 | 0.190 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2022 | 131 | 0.190 |
Why?
|
| Flavonoids | 2 | 2022 | 109 | 0.180 |
Why?
|
| Ligands | 1 | 2021 | 317 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 331 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2014 | 1745 | 0.180 |
Why?
|
| Anthelmintics | 3 | 2007 | 8 | 0.180 |
Why?
|
| Lipids | 1 | 2022 | 298 | 0.180 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 163 | 0.180 |
Why?
|
| Calcium | 4 | 2013 | 929 | 0.180 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 247 | 0.180 |
Why?
|
| Propylamines | 1 | 2000 | 22 | 0.180 |
Why?
|
| Drug Resistance, Microbial | 1 | 2020 | 70 | 0.180 |
Why?
|
| Rosales | 1 | 2000 | 2 | 0.180 |
Why?
|
| Botrytis | 1 | 2000 | 2 | 0.180 |
Why?
|
| Melanoma | 2 | 2000 | 335 | 0.180 |
Why?
|
| Computational Biology | 1 | 2021 | 190 | 0.180 |
Why?
|
| Hepatitis B | 2 | 2015 | 42 | 0.180 |
Why?
|
| Rhamnose | 1 | 2019 | 1 | 0.170 |
Why?
|
| Picrates | 2 | 2018 | 2 | 0.170 |
Why?
|
| Stilbenes | 1 | 2000 | 57 | 0.170 |
Why?
|
| Candida albicans | 4 | 2016 | 39 | 0.170 |
Why?
|
| Peroxides | 2 | 2014 | 23 | 0.170 |
Why?
|
| Bridged Bicyclo Compounds | 1 | 1999 | 29 | 0.170 |
Why?
|
| Leukemia P388 | 4 | 2006 | 4 | 0.170 |
Why?
|
| Xanthones | 1 | 1998 | 2 | 0.160 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 1999 | 82 | 0.160 |
Why?
|
| Malaria | 3 | 2006 | 26 | 0.160 |
Why?
|
| Biphenyl Compounds | 2 | 2018 | 184 | 0.160 |
Why?
|
| Quantum Theory | 1 | 2018 | 21 | 0.160 |
Why?
|
| Chemoprevention | 1 | 2018 | 26 | 0.160 |
Why?
|
| Penicillium | 1 | 2018 | 3 | 0.160 |
Why?
|
| Morus | 1 | 2018 | 2 | 0.160 |
Why?
|
| Parasitic Sensitivity Tests | 2 | 2008 | 8 | 0.150 |
Why?
|
| Catalytic Domain | 3 | 2018 | 99 | 0.150 |
Why?
|
| Catalysis | 2 | 2012 | 123 | 0.150 |
Why?
|
| Food | 1 | 2018 | 52 | 0.150 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 57 | 0.150 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 2 | 2008 | 57 | 0.150 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2007 | 373 | 0.150 |
Why?
|
| Free Radical Scavengers | 1 | 2018 | 112 | 0.150 |
Why?
|
| Acetamides | 1 | 2017 | 17 | 0.150 |
Why?
|
| Anticoagulants | 3 | 2007 | 356 | 0.150 |
Why?
|
| Proteomics | 1 | 2019 | 246 | 0.150 |
Why?
|
| Amino Acid Sequence | 4 | 2014 | 1083 | 0.140 |
Why?
|
| Molecular Sequence Data | 5 | 2013 | 1447 | 0.140 |
Why?
|
| Fatty Acid Synthases | 1 | 2016 | 6 | 0.140 |
Why?
|
| Cnidaria | 1 | 1996 | 2 | 0.140 |
Why?
|
| Piperidones | 1 | 2016 | 2 | 0.140 |
Why?
|
| Invertebrates | 2 | 2007 | 8 | 0.130 |
Why?
|
| Virus Replication | 2 | 2015 | 104 | 0.130 |
Why?
|
| Mississippi | 3 | 2014 | 11 | 0.130 |
Why?
|
| Ebolavirus | 1 | 2015 | 2 | 0.130 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2015 | 9 | 0.130 |
Why?
|
| Dengue | 1 | 2015 | 5 | 0.130 |
Why?
|
| Combinatorial Chemistry Techniques | 2 | 2007 | 25 | 0.130 |
Why?
|
| Female | 6 | 2021 | 38074 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 331 | 0.130 |
Why?
|
| Herpes Zoster | 1 | 2015 | 43 | 0.130 |
Why?
|
| Hydrolysis | 1 | 2015 | 144 | 0.130 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 2006 | 85 | 0.120 |
Why?
|
| HIV | 3 | 2001 | 56 | 0.120 |
Why?
|
| Papillomaviridae | 1 | 2015 | 104 | 0.120 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2015 | 123 | 0.120 |
Why?
|
| Iridoid Glucosides | 1 | 2014 | 1 | 0.120 |
Why?
|
| Iridoids | 1 | 2014 | 4 | 0.120 |
Why?
|
| Calibration | 2 | 2006 | 73 | 0.120 |
Why?
|
| Cryptococcus | 1 | 2014 | 7 | 0.120 |
Why?
|
| United States | 2 | 2020 | 7367 | 0.120 |
Why?
|
| Acetylcholinesterase | 1 | 2014 | 19 | 0.120 |
Why?
|
| Norisoprenoids | 1 | 2014 | 7 | 0.120 |
Why?
|
| Rhododendron | 1 | 2014 | 3 | 0.120 |
Why?
|
| Meteorology | 1 | 2014 | 1 | 0.120 |
Why?
|
| Coral Reefs | 1 | 2014 | 2 | 0.120 |
Why?
|
| HMGB1 Protein | 1 | 2014 | 23 | 0.120 |
Why?
|
| Cyclohexanones | 1 | 2014 | 9 | 0.120 |
Why?
|
| Glucosides | 1 | 2014 | 16 | 0.120 |
Why?
|
| Cystine-Knot Miniproteins | 1 | 2013 | 1 | 0.120 |
Why?
|
| Water Pollutants | 1 | 2014 | 31 | 0.120 |
Why?
|
| Crystallization | 2 | 2004 | 57 | 0.110 |
Why?
|
| Gastropoda | 1 | 2013 | 2 | 0.110 |
Why?
|
| Mycoplasma | 1 | 2013 | 10 | 0.110 |
Why?
|
| Temperature | 2 | 2018 | 341 | 0.110 |
Why?
|
| Species Specificity | 1 | 2014 | 303 | 0.110 |
Why?
|
| Cyanobacteria | 2 | 2003 | 4 | 0.110 |
Why?
|
| Down-Regulation | 1 | 2015 | 447 | 0.110 |
Why?
|
| Epigenomics | 1 | 2013 | 29 | 0.110 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 504 | 0.110 |
Why?
|
| Kinetics | 5 | 2018 | 1047 | 0.110 |
Why?
|
| Hydrogen Bonding | 1 | 2013 | 67 | 0.110 |
Why?
|
| Hexanes | 1 | 2012 | 7 | 0.100 |
Why?
|
| Amyloid beta-Peptides | 1 | 2014 | 191 | 0.100 |
Why?
|
| Environmental Monitoring | 1 | 2014 | 180 | 0.100 |
Why?
|
| Colony Count, Microbial | 2 | 2009 | 77 | 0.100 |
Why?
|
| Alkylation | 1 | 2012 | 26 | 0.100 |
Why?
|
| Pneumonia, Viral | 1 | 2015 | 154 | 0.100 |
Why?
|
| Cardiovascular Agents | 2 | 2003 | 82 | 0.100 |
Why?
|
| Agelas | 1 | 2012 | 1 | 0.100 |
Why?
|
| Chickens | 2 | 2016 | 232 | 0.100 |
Why?
|
| Liver X Receptors | 1 | 2012 | 8 | 0.100 |
Why?
|
| Arctic Regions | 1 | 2011 | 4 | 0.100 |
Why?
|
| CHO Cells | 1 | 2012 | 161 | 0.100 |
Why?
|
| Cricetinae | 1 | 2012 | 262 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 2 | 2013 | 322 | 0.100 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2003 | 73 | 0.100 |
Why?
|
| Sepsis | 1 | 2014 | 233 | 0.090 |
Why?
|
| Harmful Algal Bloom | 1 | 2010 | 1 | 0.090 |
Why?
|
| Pentacyclic Triterpenes | 2 | 2000 | 3 | 0.090 |
Why?
|
| Lactams | 1 | 2010 | 4 | 0.090 |
Why?
|
| Tryptamines | 1 | 2010 | 7 | 0.090 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2008 | 137 | 0.090 |
Why?
|
| Indian Ocean | 2 | 2008 | 8 | 0.090 |
Why?
|
| Mice, Nude | 1 | 2011 | 294 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2008 | 2550 | 0.090 |
Why?
|
| Pyrrolidines | 1 | 2010 | 45 | 0.090 |
Why?
|
| Time Factors | 3 | 2009 | 4655 | 0.090 |
Why?
|
| Baccharis | 1 | 2010 | 1 | 0.090 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2010 | 34 | 0.090 |
Why?
|
| Spectrophotometry, Infrared | 3 | 2000 | 25 | 0.090 |
Why?
|
| Hydrostatic Pressure | 1 | 2009 | 11 | 0.090 |
Why?
|
| Piperidines | 1 | 2010 | 123 | 0.090 |
Why?
|
| Food Microbiology | 1 | 2009 | 24 | 0.090 |
Why?
|
| Consumer Product Safety | 1 | 2009 | 32 | 0.090 |
Why?
|
| Rhodophyta | 1 | 2009 | 1 | 0.090 |
Why?
|
| Leishmania | 1 | 2009 | 6 | 0.090 |
Why?
|
| Food Contamination | 1 | 2009 | 56 | 0.090 |
Why?
|
| Trypanocidal Agents | 1 | 2009 | 11 | 0.090 |
Why?
|
| Taste | 1 | 2009 | 49 | 0.090 |
Why?
|
| Consumer Behavior | 1 | 2009 | 68 | 0.080 |
Why?
|
| Hepacivirus | 1 | 2010 | 90 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2006 | 2077 | 0.080 |
Why?
|
| Sesquiterpenes, Guaiane | 1 | 2008 | 3 | 0.080 |
Why?
|
| Zebrafish | 1 | 2010 | 187 | 0.080 |
Why?
|
| Furocoumarins | 1 | 2008 | 9 | 0.080 |
Why?
|
| Spectrometry, Mass, Fast Atom Bombardment | 2 | 2000 | 7 | 0.080 |
Why?
|
| Muscle, Skeletal | 3 | 1996 | 396 | 0.080 |
Why?
|
| Aquaculture | 1 | 2008 | 4 | 0.080 |
Why?
|
| Male | 7 | 2012 | 37321 | 0.080 |
Why?
|
| Methylation | 1 | 2008 | 56 | 0.080 |
Why?
|
| Kidney | 2 | 2008 | 945 | 0.080 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2008 | 46 | 0.080 |
Why?
|
| Erythrocytes | 1 | 2008 | 137 | 0.080 |
Why?
|
| Chromatography, Liquid | 2 | 2018 | 120 | 0.080 |
Why?
|
| Microbiological Techniques | 1 | 2007 | 9 | 0.070 |
Why?
|
| Esterification | 1 | 2007 | 25 | 0.070 |
Why?
|
| HIV Infections | 1 | 2015 | 791 | 0.070 |
Why?
|
| Opportunistic Infections | 1 | 2007 | 33 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 694 | 0.070 |
Why?
|
| Florida | 1 | 2008 | 221 | 0.070 |
Why?
|
| Neurons | 1 | 2013 | 881 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2008 | 220 | 0.070 |
Why?
|
| Caspase 3 | 2 | 2022 | 233 | 0.070 |
Why?
|
| Microglia | 1 | 2008 | 143 | 0.070 |
Why?
|
| Chloroquine | 1 | 2006 | 21 | 0.070 |
Why?
|
| Oryzias | 1 | 2006 | 7 | 0.070 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 2006 | 3 | 0.070 |
Why?
|
| Eukaryotic Cells | 1 | 2006 | 7 | 0.070 |
Why?
|
| Toxicity Tests | 1 | 2006 | 26 | 0.070 |
Why?
|
| Serotonin Agents | 1 | 2005 | 13 | 0.070 |
Why?
|
| Receptors, Nicotinic | 2 | 1996 | 41 | 0.070 |
Why?
|
| Reference Standards | 1 | 2006 | 115 | 0.070 |
Why?
|
| Patents as Topic | 1 | 2005 | 4 | 0.070 |
Why?
|
| Drug Resistance | 1 | 2006 | 223 | 0.060 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2005 | 26 | 0.060 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2005 | 58 | 0.060 |
Why?
|
| Guanidine | 1 | 2004 | 7 | 0.060 |
Why?
|
| Drug Evaluation | 1 | 2004 | 47 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2005 | 59 | 0.060 |
Why?
|
| Fourier Analysis | 1 | 2004 | 31 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2006 | 714 | 0.060 |
Why?
|
| Biological Availability | 1 | 2004 | 79 | 0.060 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2001 | 59 | 0.060 |
Why?
|
| Immunologic Factors | 1 | 2004 | 87 | 0.060 |
Why?
|
| Injections, Intravenous | 1 | 2004 | 215 | 0.060 |
Why?
|
| Methanol | 1 | 2003 | 9 | 0.060 |
Why?
|
| Eukaryota | 1 | 2003 | 10 | 0.060 |
Why?
|
| Agrochemicals | 1 | 2003 | 3 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2008 | 902 | 0.050 |
Why?
|
| Agaricales | 1 | 2003 | 2 | 0.050 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2022 | 11 | 0.050 |
Why?
|
| Antarctic Regions | 1 | 2002 | 5 | 0.050 |
Why?
|
| Phenylacetates | 1 | 2003 | 18 | 0.050 |
Why?
|
| Quinolizines | 1 | 2002 | 4 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 112 | 0.050 |
Why?
|
| Sequence Analysis, Protein | 1 | 2002 | 16 | 0.050 |
Why?
|
| Anticarcinogenic Agents | 1 | 2003 | 52 | 0.050 |
Why?
|
| Alkaline Phosphatase | 1 | 2022 | 71 | 0.050 |
Why?
|
| Endocrine Glands | 1 | 2002 | 7 | 0.050 |
Why?
|
| Solvents | 1 | 2003 | 109 | 0.050 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2022 | 10 | 0.050 |
Why?
|
| Cold Temperature | 1 | 2002 | 90 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2014 | 362 | 0.050 |
Why?
|
| Cell Fusion | 3 | 1996 | 23 | 0.050 |
Why?
|
| Central Nervous System Agents | 1 | 2002 | 37 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 174 | 0.050 |
Why?
|
| Phenols | 1 | 2022 | 73 | 0.050 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2001 | 9 | 0.050 |
Why?
|
| Osteoblasts | 1 | 2022 | 99 | 0.050 |
Why?
|
| Lipogenesis | 1 | 2021 | 9 | 0.050 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2001 | 67 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 1753 | 0.050 |
Why?
|
| Necrosis | 1 | 2022 | 239 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2022 | 304 | 0.050 |
Why?
|
| Toxoplasmosis | 1 | 2001 | 13 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2004 | 2083 | 0.050 |
Why?
|
| Toxoplasma | 1 | 2001 | 23 | 0.050 |
Why?
|
| Osteogenesis | 1 | 2022 | 152 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2022 | 110 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2013 | 85 | 0.050 |
Why?
|
| Antioxidants | 1 | 2003 | 304 | 0.050 |
Why?
|
| DNA, Bacterial | 2 | 2013 | 150 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 2 | 2013 | 208 | 0.050 |
Why?
|
| Tuberculosis | 1 | 2001 | 77 | 0.040 |
Why?
|
| Phylogeny | 2 | 2013 | 197 | 0.040 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2000 | 72 | 0.040 |
Why?
|
| Dimerization | 1 | 2000 | 99 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2003 | 514 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2000 | 222 | 0.040 |
Why?
|
| Solanaceous Alkaloids | 1 | 1998 | 2 | 0.040 |
Why?
|
| Aldehyde Reductase | 1 | 2018 | 3 | 0.040 |
Why?
|
| PC12 Cells | 1 | 2018 | 36 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2018 | 67 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2022 | 1034 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2022 | 718 | 0.040 |
Why?
|
| Proteolysis | 1 | 2018 | 97 | 0.040 |
Why?
|
| Steroids | 1 | 2018 | 84 | 0.040 |
Why?
|
| Plants, Toxic | 1 | 1997 | 33 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 139 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2019 | 382 | 0.040 |
Why?
|
| Algorithms | 1 | 2003 | 1196 | 0.040 |
Why?
|
| Brain | 1 | 2008 | 2176 | 0.040 |
Why?
|
| Sophora | 1 | 2016 | 2 | 0.040 |
Why?
|
| Carbon-13 Magnetic Resonance Spectroscopy | 1 | 2016 | 2 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 314 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2018 | 791 | 0.030 |
Why?
|
| A549 Cells | 1 | 2016 | 50 | 0.030 |
Why?
|
| CDPdiacylglycerol-Serine O-Phosphatidyltransferase | 1 | 2016 | 2 | 0.030 |
Why?
|
| Drug Antagonism | 1 | 2016 | 6 | 0.030 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2016 | 27 | 0.030 |
Why?
|
| HT29 Cells | 1 | 1996 | 42 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2016 | 80 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 74 | 0.030 |
Why?
|
| Potassium Channels | 1 | 1996 | 55 | 0.030 |
Why?
|
| Tendons | 1 | 1996 | 45 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2016 | 162 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 1996 | 200 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2016 | 48 | 0.030 |
Why?
|
| Potassium | 1 | 1996 | 168 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2022 | 2791 | 0.030 |
Why?
|
| Cell Death | 1 | 2016 | 329 | 0.030 |
Why?
|
| Renin | 1 | 1995 | 96 | 0.030 |
Why?
|
| Endothelins | 1 | 1995 | 57 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 1056 | 0.030 |
Why?
|
| Protein Binding | 1 | 2018 | 1027 | 0.030 |
Why?
|
| Nicotinic Agonists | 1 | 1995 | 111 | 0.030 |
Why?
|
| In Vitro Techniques | 3 | 2006 | 765 | 0.030 |
Why?
|
| Pepsin A | 1 | 2014 | 8 | 0.030 |
Why?
|
| Chymotrypsin | 1 | 2014 | 11 | 0.030 |
Why?
|
| Water Pollution | 1 | 2014 | 10 | 0.030 |
Why?
|
| Pancreatic Elastase | 1 | 2014 | 33 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2014 | 69 | 0.030 |
Why?
|
| Trypsin | 1 | 2014 | 64 | 0.030 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2014 | 58 | 0.030 |
Why?
|
| Biodiversity | 1 | 2013 | 16 | 0.030 |
Why?
|
| Computer-Aided Design | 1 | 2014 | 101 | 0.030 |
Why?
|
| Protein Stability | 1 | 2013 | 90 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2013 | 136 | 0.030 |
Why?
|
| Veratridine | 1 | 2013 | 4 | 0.030 |
Why?
|
| Sodium Channels | 1 | 2013 | 24 | 0.030 |
Why?
|
| Ion Transport | 1 | 2013 | 26 | 0.030 |
Why?
|
| Australia | 1 | 2014 | 235 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2013 | 56 | 0.030 |
Why?
|
| Protein Folding | 1 | 2013 | 82 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2001 | 1173 | 0.030 |
Why?
|
| Action Potentials | 1 | 2013 | 223 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 3 | 1996 | 204 | 0.020 |
Why?
|
| Aspergillus fumigatus | 1 | 2011 | 27 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 306 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2012 | 175 | 0.020 |
Why?
|
| Caco-2 Cells | 1 | 2010 | 37 | 0.020 |
Why?
|
| Mediterranean Sea | 1 | 2009 | 1 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2013 | 415 | 0.020 |
Why?
|
| Pentamidine | 1 | 2009 | 7 | 0.020 |
Why?
|
| Leishmaniasis | 1 | 2009 | 4 | 0.020 |
Why?
|
| Italy | 1 | 2009 | 36 | 0.020 |
Why?
|
| Amphotericin B | 1 | 2009 | 26 | 0.020 |
Why?
|
| Homeostasis | 1 | 2011 | 291 | 0.020 |
Why?
|
| DNA Replication | 1 | 2010 | 167 | 0.020 |
Why?
|
| Rhizome | 1 | 2008 | 3 | 0.020 |
Why?
|
| Genes, rRNA | 1 | 2008 | 8 | 0.020 |
Why?
|
| Hindlimb Suspension | 1 | 2007 | 11 | 0.020 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2007 | 45 | 0.020 |
Why?
|
| Desipramine | 1 | 2007 | 47 | 0.020 |
Why?
|
| Citalopram | 1 | 2007 | 30 | 0.020 |
Why?
|
| Swimming | 1 | 2007 | 38 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2007 | 120 | 0.020 |
Why?
|
| Cells, Cultured | 3 | 1996 | 2673 | 0.020 |
Why?
|
| RNA, Transfer, Phe | 1 | 2006 | 1 | 0.020 |
Why?
|
| Puromycin | 1 | 2006 | 3 | 0.020 |
Why?
|
| Peptide Elongation Factor 2 | 1 | 2006 | 14 | 0.020 |
Why?
|
| Ribosomes | 1 | 2006 | 23 | 0.020 |
Why?
|
| Electrophysiology | 2 | 1996 | 160 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 271 | 0.010 |
Why?
|
| Motor Activity | 1 | 2007 | 621 | 0.010 |
Why?
|
| Fungicides, Industrial | 1 | 2003 | 7 | 0.010 |
Why?
|
| Herbicides | 1 | 2003 | 24 | 0.010 |
Why?
|
| Insecticides | 1 | 2003 | 43 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2003 | 122 | 0.010 |
Why?
|
| Rifampin | 1 | 2002 | 45 | 0.010 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2003 | 114 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2006 | 1664 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2006 | 753 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2003 | 532 | 0.010 |
Why?
|
| Herpesvirus 1, Human | 1 | 2001 | 30 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2000 | 351 | 0.010 |
Why?
|
| Child, Preschool | 2 | 1996 | 3187 | 0.010 |
Why?
|
| Libya | 1 | 1998 | 1 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1998 | 45 | 0.010 |
Why?
|
| Mycobacterium | 1 | 1998 | 12 | 0.010 |
Why?
|
| Charybdotoxin | 1 | 1996 | 1 | 0.010 |
Why?
|
| Elapid Venoms | 1 | 1996 | 5 | 0.010 |
Why?
|
| Tubocurarine | 1 | 1996 | 3 | 0.010 |
Why?
|
| Potassium Channel Blockers | 1 | 1996 | 32 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1996 | 78 | 0.010 |
Why?
|
| Aminopyridines | 1 | 1996 | 26 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1996 | 64 | 0.010 |
Why?
|
| Carbachol | 1 | 1995 | 34 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1996 | 61 | 0.010 |
Why?
|
| Viper Venoms | 1 | 1995 | 8 | 0.010 |
Why?
|
| Endothelin Receptor Antagonists | 1 | 1995 | 17 | 0.010 |
Why?
|
| Receptors, Endothelin | 1 | 1995 | 30 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1995 | 163 | 0.010 |
Why?
|
| Microtubules | 1 | 1995 | 104 | 0.010 |
Why?
|
| Perfusion | 1 | 1995 | 131 | 0.010 |
Why?
|
| Child | 2 | 1996 | 6405 | 0.010 |
Why?
|
| Sulfonamides | 1 | 1995 | 141 | 0.010 |
Why?
|
| Adolescent | 2 | 1996 | 8912 | 0.010 |
Why?
|
| Infant | 1 | 1996 | 2891 | 0.010 |
Why?
|
| Signal Transduction | 1 | 1995 | 2689 | 0.000 |
Why?
|
| Middle Aged | 1 | 1996 | 21147 | 0.000 |
Why?
|
| Adult | 1 | 1996 | 21403 | 0.000 |
Why?
|